Newly Diagnosed Glioblastoma – Current clinical trial: Diffusion Pharmaceuticals is sponsoring an FDA-authorized clinical trial to examine the efficacy and safety of TSC administered concomitantly with radiation therapy and temozolomide (Temodar; Merck & Co.) for patients with newly diagnosed glioblastoma (GBM) brain tumors. This trial is fully enrolled and no longer recruiting patients.
Further information is available at http://www.clinicaltrials.gov/ct2/show/NCT01465347?term=tsc&rank=4
Brain Metastasis – Planned: Diffusion Pharmaceuticals is preparing for a clinical trial of TSC plus radiation therapy for patients with brain metastasis. Please check back on this website to follow the progress of this clinical program.